Bioactive Glass S53P4 in the Filling of Cavities in the Mastoid Cell Area in Surgery for Chronic Otitis Media

被引:53
|
作者
Stoor, Patricia [2 ]
Pulkkinen, Jaakko [1 ]
Grenman, Reidar [1 ]
机构
[1] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Turku 20521, Finland
[2] Helsinki Univ Cent Hosp, Dept Maxillofacial Surg, Helsinki, Finland
来源
关键词
bioactive glass; otitis media; surgical treatment; CANAL WALL; SEPTAL PERFORATIONS; OBLITERATION; RECONSTRUCTION; BONE; HYDROXYLAPATITE; HYDROXYAPATITE; MICROORGANISMS; EXPERIENCE; GRANULES;
D O I
10.1177/000348941011900603
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: Chronic infection of the middle ear and cholesteatoma can be treated surgically by exenteration of the mastoid air cells behind the ear. After a procedure with the canal wall-down technique, a cavity remains that is sometimes difficult to clean, collects crust, and becomes repeatedly infected. Such problematic mastoid cavities can he eliminated by filling the created cavity surgically after thorough removal of mucous membranes and cleaning of the bone. Methods: We treated 7 patients with cavities after canal wall-down surgery for the treatment of chronic suppurative otitis media or cholesteatoma by filling the difficult-to-clean cavity in the mastoid cell area with granules of bioactive glass (BAG) S53P4 to avoid further retraction formation, The area with BAG was carefully closed with a musculoperiosteal flap. Results: After the canal wall down tympanomastoidectomy, the mastoid cavities were successfully filled in all 7 patients. No biomaterial-associated infection was seen, and no disadvantages for the patients due to the BAG were observed. The cavity in the mastoid cell area decreased in size in all patients treated. Conclusions: This BAG seems to be a promising material for filling mastoid cavities after canal wall-down tympanomastoidectomy.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 50 条
  • [1] Bioactive Glass S53P4 in Mastoid Obliteration Surgery for Chronic Otitis Media and Cerebrospinal Fluid Leakage
    Sarin, Jussi
    Grenman, Reidar
    Aitasalo, Kalle
    Pulkkinen, Jaakko
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2012, 121 (09): : 563 - 569
  • [2] Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery
    Mestdagh, Pieter D. de Veij
    Colnot, David R.
    Borggreven, Pepijn A.
    Orelio, Claudia C.
    Quak, Jasper J.
    [J]. ACTA OTO-LARYNGOLOGICA, 2017, 137 (07) : 690 - 694
  • [3] Antibiotics in mastoid and epitympanic obliteration with S53P4 bioactive glass: A retrospective study
    Alciato, Lauranne
    Bernardeschi, Daniele
    Pourcher, Valerie
    Mkrtchyan, Naira
    Tankere, Frederic
    Sterkers, Olivier
    Lahlou, Ghizlene
    [J]. LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2022, 7 (05): : 1584 - 1594
  • [4] Management of tegmen defects with mastoid and epitympanic obliteration using S53P4 bioactive glass
    Remangeon, Francoise
    Lahlou, Ghizlene
    Alciato, Lauranne
    Tankere, Frederic
    Mosnier, Isabelle
    Sterkers, Olivier
    Pyatigorskaya, Nadya
    Bernardeschi, Daniele
    [J]. LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (02): : 297 - 304
  • [5] Implantation of two generations of Bonebridge after mastoid obliteration with bioactive glass S53P4
    Skarzynski, Piotr H.
    Krol, Bartlomiej
    Skarzynski, Henryk
    Cywka, Katarzyna B.
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (05)
  • [6] Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study
    Bernardeschi, Daniele
    Nguyen, Yann
    Russo, Francesca Yoshie
    Mosnier, Isabelle
    Ferrary, Evelyne
    Sterkers, Olivier
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [7] Efficacy of S53P4 Bioactive Glass for the Secondary Obliteration of Chronically Discharging Radical Cavities
    Kroon, Victor J.
    Mes, Steven W.
    Borggreven, Pepijn A.
    van de Langenberg, Rick
    Colnot, David R.
    Quak, Jasper J.
    [J]. OTO OPEN, 2023, 7 (04)
  • [8] Through the looking glass; bioactive glass S53P4 (BonAliveA®) in the treatment of chronic osteomyelitis
    McAndrew, J.
    Efrimescu, C.
    Sheehan, E.
    Niall, D.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 (03) : 509 - 511
  • [9] Through the looking glass; bioactive glass S53P4 (BonAlive®) in the treatment of chronic osteomyelitis
    J. McAndrew
    C. Efrimescu
    E. Sheehan
    D. Niall
    [J]. Irish Journal of Medical Science, 2013, 182 : 509 - 511
  • [10] In vitro dissolution of bioactive glass S53P4 microspheres
    Sinitsyna, Polina
    Karlstrom, Oskar
    Hupa, Leena
    [J]. JOURNAL OF THE AMERICAN CERAMIC SOCIETY, 2022, 105 (03) : 1658 - 1670